Enliven Therapeutics Inc (ELVN)

Cash & Short-Term Investments

$895.16M

Quarterly · Period ending: · USD

ELVN logo

ELVN Cash & Short-Term Investments

Latest reported$895.16M
ELVN Quarterly Cash & Short-Term Investments ($28.91M → $895.16M)
High-resolution chart · PNG

ELVN cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Enliven Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
895,155,000
452,401,000
462,621,000
477,565,000
490,503,000
289,555,000
313,440,000
291,834,000
312,390,000
320,504,000
253,148,000
263,478,000
277,865,000
292,102,000
75,536,000
86,159,000
60,340,000
72,900,000
110,024,000
102,839,000
66,768,000
75,592,000
88,222,000
96,089,000
106,275,000
105,867,000
28,907,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.